FHMLSP, L.L.C. — SEC insider filings
SEC reporting owner CIK 1879465. 4 insider filings on record with FilingPulse; latest filed 2026-10-15.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2021-09-28 to 2026-10-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 500,000 shares, $5,200,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: purchase of 300,000 shares @ $10.00 ($3,000,000) in Frazier Life Sciences Acquisition Corp. II, filed 2026-10-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Frazier Life Sciences Acquisition Corp. II (FLSC) | 10% owner | 2 | 1 leg · 300,000 sh · $3,000,000 | — | — |
| Viridian Therapeutics, Inc.\DE (VRDN) | 10% owner | 1 | 1 leg · 200,000 sh · $2,200,000 | — | — |
| Adverum Biotechnologies, Inc. (ADVM) | 10% owner | 1 | — | — | 1 |
Insider filings — FHMLSP, L.L.C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-15 | 4 | Frazier Life Sciences Acquisition Corp. II (FLSC) jointly with Cha Albert, Frazier Life Sciences Holdings II LLC, Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P. | Purchase (P): 300,000 @ $10 | EDGAR |
| 2026-10-13 | 3 | Frazier Life Sciences Acquisition Corp. II (FLSC) jointly with Cha Albert, Frazier Life Sciences Holdings II LLC, Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P. | Holdings only — no transactions reported | EDGAR |
| 2025-12-09 | 4 | Adverum Biotechnologies, Inc. (ADVM) jointly with Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P. | Code (U): 4,288,949 @ $3.56 | EDGAR |
| 2021-09-28 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) jointly with Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P. | Purchase (P): 200,000 @ $11 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1879465 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs